Michael Mannstadt, MD is Chief of the Endocrine Unit at the Massachusetts General Hospital and Associate Professor in Medicine at Harvard Medical School. His clinical and research interests focus on diseases of the parathyroid glands. He is particularly interested in hypoparathyroidism, and his research spans the basic, translational, and clinical realms of the disease. He is the principal investigator of an NIH grant for the development of a long-acting PTH, and the lead author of the phase 3 clinical trial of PTH(1-84) in hypoparathyroidism. Dr. Mannstadt also hopes that the Natpara recall is soon over. He is a medical advisor for the Hypoparathyroid Association and a frequent faculty participant at their annual patient meetings.
Dr. Dolores Shoback
Dr. Dolores Shoback is Professor of Medicine and Associate Program Director of the Fellowship Program in Diabetes, Endocrinology and Metabolism at the University of California, San Francisco School of Medicine. She graduated from the University of Pennsylvania (BA, Biology) and Johns Hopkins University School of Medicine (MD). After Medicine residency at Johns Hopkins Hospital and fellowship in Endocrinology and Hypertension at the Brigham and Women’s Hospital/Harvard Medical School, she joined the faculty in 1985 in the Endocrine Research Unit at the San Francisco Veterans Affairs Medical Center and the University of California, San Francisco. She is active in basic and clinical research involving calcium-sensing receptors, parathyroid disorders, and calcium-sensing receptors. She has authored more than 150 research papers, reviews and chapters and co-edited the last 3 editions of the Greenspan Textbook of Endocrinology and Metabolism.
Dr. Lynn Kohlmeier is director of Endocrinology and Spokane Osteoporosis as well as an independent practitioner. Her involvement as Principal Investigator and Sub-Investigator in research studies on bone mineral density, bone quality tests, fracture assessment and osteoporosis, has resulted in multiple publications. She is a reviewer for the Journal of Clinical Densitometry, Metabolism, and Osteoporosis International and is an executive board member for Advances in Mineral Metabolism/American Society for Bone and Mineral Research. Dr Kohlmeier is recognized as a national speaker for metabolic bone disease and osteoporosis. She gives presentations on parathyroid and thyroid disease, testosterone and estrogen replacement, vitamin D, as well as, rare bone disease to primary care providers, specialists, medical students, physician assistant and nurse practitioner students and family medicine residents.
Dr. Aliya Khan
Dr. Khan is a professor of Clinical Medicine, Divisions of Endocrinology and Metabolism and Geriatrics at McMaster University and Director of the Calcium Disorders Clinic at St. Joseph's Healthcare, McMaster University. She graduated from University of Ottawa Medical School with Honors and completed post-graduate training at the University of Toronto. She has published over 100 scientific papers on osteoporosis and parathyroid disease as well as numerous book chapters. She is the Editor of the Handbook of Parathyroid Diseases. Dr. Khan has been recognized by national and international awards including the International Clinician Instructor of the Year 2011 award by the International Society of Clinical Densitometry (ISCD), the Queen's Diamond Jubilee Medal for 2012 for excellence in clinical care, research and teaching as well as the International Hypoparathyroidism Award for 2014.
Dr. Gafni received her BA from Barnard College and her MD from Temple University. She completed a pediatric residency at the Children's Hospital of Philadelphia followed by a pediatric endocrinology fellowship at the National Institute of Health (NIH), serving as an officer in the Public Health Service from 1996-2002. She subsequently served as an Assistant Professor at the University of Maryland. Dr. Gafni returned to NIH in 2007 as a staff clinician in the National Institute od Dental and Craniofacial Research. She is also faculty in the NIH Pediatric Endocrinology and NIH Inter-institute Adult Endocrinology Training Programs. She is an investigator on several protocols studying and treating patients with endocrine disorders including hypoparathyroidism, McCune-Albright Syndrome, hypophosphatemic rickets, hyperphosphatemic familial humoral calcinosis, generalized arterial calcification of infancy, and other metabolic bone diseases.
Dr. Michael Levine
Dr. Levine is chief of the Division of Endocrinology and Diabetes and Director of the Center for Bone Health at the Children's Hospital of Philadelphia. He is a Professor of Pediatrics and Medicine at the University of Pennsylvania Perelman School of Medicine and he holds the Lester Baker Endowed Chair in Pediatric Diabetes. His primary clinical interests are endocrine diseases that affect bone and mineral metabolism, particularly osteoporosis, primary hyperparathyroidism, hypoparathyroidism, rickets and genetic bone disease. Dr. Levine has an active laboratory research program that complements and extends his clinical studies. He has identified the molecular basis of several inherited disorders of mineral metabolism. He is a member of numerous professional societies, including the American Society for Bone and Mineral Research, American Society for Clinical Investigation, Association of American College of Endocrinology and the American Academy of Pediatrics. In 2018 Dr. Levine received the Frederic C. Bartter Award from the American Society of Bone and Mineral Research. Since 2005 Dr. Levine has been named as One of America's Best Doctors.
Dr. Daniel Ruan
Dr. Ruan is a parathyroid surgeon specialist at the Norman Parathyroid Center in Tampa Florida. He completed his medical degree from Duke University, surgical training at Brigham and Women's Hospital, and Endocrine Surgery fellowship at the University of California, San Francisco. Dr. Ruan has been in practice as an endocrine surgeon for over a decade. His current practice is dedicated exclusively to the diagnosis and surgical management of primary hyperparathyroidism in the highest volume surgical group in the world. Dr. Ruan was previously the fellowship Program Director of Endocrine Surgery, the Director of Endocrine Oncologic Research, and Assistant Professor of Surgery at Brigham and Women's/Harvard Medical School. He is a member of the American Association of Endocrine Surgeons Parathyroidectomy Guidelines Committee and the Board of Medical Advisors for the HypoPARAthyroidism Association, Inc. Dr. Ruan is a former Research Scholar of the American Cancer Society, Fellow in the Pandolfi Cancer Genetics Group at Harvard Medical School and he is currently the Director of Translational Research at the Norman Parathyroid Center. He is the Co-Director of the Oakstone Institute, Endocrine and Head and Neck Surgery Course and he has published over 15 textbook chapters and 65 peer-reviewed research articles.
Blaine Everson, LMFT, PhD
Blaine Everson, PhD. is a marriage and family therapist in private practice in Athens, Ga. where he has been Clinical Director with the Samaritan Counseling Center since 2007. Previously he worked 6 years at the Frasier Center in Hinesville, Ga. near a major Army base. His practice history includes extensive work with military families and readjustment issues associated with military service, along with a special interest in the recovery from emotional trauma at the familial level. He recently co-authored and edited 'Families Under Fire: Systemic Therapy with Military Families' with Charles R. Figley, published in 2010 by Routledge.
Dr. Mishaela Rubin
Dr. Rubin graduated from Barnard College in 1991 and obtained her medical degree from Columbia University's College of P&S in 1995. She went on to do her medical residency and Endocrine Fellowship at Columbia University. She subsequently joined the faculty of Columbia University's Endocrine Division in 2002 as a member of the Metabolic Bone Diseases Unit. In 2006 she completed a Master's degree in statistics at the Mailman School of Public Health and in 2008 she became an Irving Scholar. She has published extensively in the metabolic bone disease field, co-authoring 31 original papers and receiving grant support from the NIH and the FDA. One of her research focuses is the treatment of hypoparathyroidism, a rare endocrine disorder. Her work in this field contributed to the recent FDA approval of a new treatment for hypoparathyroid patients.
Dr. Diane Krause
Originally from Pittsburgh, Pa, Dr. Krause received an Sc.B. degree in Biology from Brown University, and an MD and PhD degree from the University of Pennsylvania. After completing a residency in Clinical Pathology at the University of Pennsylvania, she performed post-doctoral studies at Johns Hopkins University.
Dr. Krause is presently Professor of Laboratory Medicine, Pathology and Cell Biology at Yale University; Associate Director of the Yale Stem Cell Center; Associate Director of Transfusion Medicine and Director of the Clinical Cell Processing Laboratory, which collects and processes cells for bone marrow transplantation. She runs the well-funded and expanding research laboratory focusing on leukemogenesis, stem cells, clinical cell therapy and pluripotent stem cell differentiation down the parathyroid lineage.
Judge Glynn F. Voisin
Honorable Glynn F. Voisin currently serves as Chief Administrative Law Judge of the Federal Mine Safety and Health Review Commission. The Commission is an independent adjudicatory agency that provides nationwide administrative trial and appellate review of legal disputes arising under the Federal Mine Safety and Health Act of 1977, as amended, with headquarters and branch office in Washington, D.C. and branch offices in Denver, Colorado and Pittsburgh, Pennsylvania. The Chief Administrative Law Judge (CALJ) is head of the Division of Judges and is solely responsible for the management and general administrative supervision of the CALJ office and the three branch offices to ensure the most expeditious and thorough conduct of proceedings coming before the Division.
Dr. Peter Tebben
Peter Tebben M.D. holds a joint appointment in the Divisions of Endocrinology in the Departments of Internal Medicine and Pediatrics at Mayo Clinic, Rochester, MN. His research interests stem from the clinical care of both children and adults with heritable and acquired skeletal dysplasias and metabolic bone disorders. Dr. Tebben earned his medical degree at the University of Kansas and completed residency in Internal Medicine and Pediatrics at the University of Minnesota. He completed his training at Mayo Clinic in Adult and Pediatric Endocrinology in 2006 where he now serves as a consultant in the Bone Core Group. Dr. Tebben has served as Chair of the Pediatric Bone and Mineral Working Group for the American Society for Bone and Mineral Research, has served as a manuscript reviewer for several bone specialty and endocrine journals, and continues to engage in clinical research of children and adults with metabolic bone disorders. He is the director of the Pediatric Metabolic Bone Clinic at Mayo Clinic.